Honglian Wu

Statistics

Publications

Citations

356

H-Index

Active since

2017

Affiliations

Huazhong University of Science and Technology(Current)

Wuhan Institute of Bioengineering

Honglian Wu is an author at Huazhong University of Science and Technology specializing in nanoparticle drug delivery, drug delivery, and cancer nanomedicine.

ORCID

Publications per year

2017–2019

Publications

Potentiating photodynamic therapy of ICG-loaded nanoparticles by depleting GSH with PEITC

Hang Hu, Jitang Chen, Hai Yang et al. · Nanoscale · 2019 · 112 citations

Pharmacy, Pharmaceutics, Pharmacology +14

Nanocolloidosomes with Selective Drug Release for Active Tumor-Targeted Imaging-Guided Photothermal/Chemo Combination Therapy

Hang Hu, Chen Xiao, Honglian Wu et al. · ACS Applied Materials & Interfaces · 2017 · 92 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Hydroxyethyl starch stabilized polydopamine nanoparticles for cancer chemotherapy

Honglian Wu, Hang Hu, Jiangling Wan et al. · Chemical Engineering Journal · 2018 · 92 citations

Pharmacy, Oncology, Pharmacology +16

Self-assembly of folic acid dextran conjugates for cancer chemotherapy

Yuxiang Tang, Yihui Li, Rong Xu et al. · Nanoscale · 2018 · 60 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +16

1–4 of 4